BlackRock’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.25B Buy
9,980,163
+420,781
+4% +$137M 0.06% 269
2025
Q1
$2.58B Sell
9,559,382
-325,875
-3% -$88M 0.05% 302
2024
Q4
$2.33B Buy
9,885,257
+177,839
+2% +$41.8M 0.05% 340
2024
Q3
$2.67B Buy
9,707,418
+159,755
+2% +$43.9M 0.06% 306
2024
Q2
$2.32B Buy
9,547,663
+522,656
+6% +$127M 0.05% 320
2024
Q1
$1.35B Buy
9,025,007
+503,892
+6% +$75.3M 0.03% 493
2023
Q4
$1.63B Buy
8,521,115
+128,111
+2% +$24.5M 0.04% 402
2023
Q3
$1.49B Buy
8,393,004
+6,842
+0.1% +$1.21M 0.04% 399
2023
Q2
$1.59B Sell
8,386,162
-162,800
-2% -$30.9M 0.04% 384
2023
Q1
$1.71B Buy
8,548,962
+59,582
+0.7% +$11.9M 0.05% 355
2022
Q4
$2.02B Buy
8,489,380
+820,702
+11% +$195M 0.06% 307
2022
Q3
$1.53B Buy
7,668,678
+6,003
+0.1% +$1.2M 0.05% 353
2022
Q2
$1.12B Buy
7,662,675
+53,721
+0.7% +$7.84M 0.04% 475
2022
Q1
$1.24B Sell
7,608,954
-62,448
-0.8% -$10.2M 0.03% 494
2021
Q4
$1.3B Sell
7,671,402
-1,249,570
-14% -$212M 0.03% 496
2021
Q3
$1.68B Buy
8,920,972
+224,569
+3% +$42.4M 0.05% 387
2021
Q2
$1.47B Sell
8,696,403
-316,082
-4% -$53.6M 0.04% 449
2021
Q1
$1.27B Buy
9,012,485
+288,765
+3% +$40.8M 0.04% 479
2020
Q4
$1.13B Sell
8,723,720
-176,450
-2% -$22.9M 0.04% 469
2020
Q3
$1.3B Sell
8,900,170
-223,281
-2% -$32.5M 0.05% 370
2020
Q2
$1.35B Buy
9,123,451
+550,598
+6% +$81.5M 0.05% 334
2020
Q1
$933M Buy
8,572,853
+539,597
+7% +$58.7M 0.05% 385
2019
Q4
$925M Buy
8,033,256
+928,087
+13% +$107M 0.04% 492
2019
Q3
$571M Buy
7,105,169
+567,916
+9% +$45.7M 0.02% 665
2019
Q2
$474M Buy
6,537,253
+109,126
+2% +$7.92M 0.02% 776
2019
Q1
$601M Buy
6,428,127
+282,322
+5% +$26.4M 0.03% 624
2018
Q4
$448M Buy
6,145,805
+61,777
+1% +$4.5M 0.02% 713
2018
Q3
$532M Sell
6,084,028
-55,242
-0.9% -$4.83M 0.02% 722
2018
Q2
$605M Sell
6,139,270
-1,038,792
-14% -$102M 0.03% 612
2018
Q1
$855M Buy
7,178,062
+62,999
+0.9% +$7.5M 0.04% 461
2017
Q4
$904M Buy
7,115,063
+1,003,366
+16% +$127M 0.04% 444
2017
Q3
$718M Buy
6,111,697
+923,506
+18% +$109M 0.04% 502
2017
Q2
$414M Buy
5,188,191
+441,957
+9% +$35.3M 0.02% 748
2017
Q1
$243M Buy
4,746,234
+4,732,617
+34,755% +$243M 0.01% 1127
2016
Q4
$509K Sell
13,617
-60,440
-82% -$2.26M ﹤0.01% 1661
2016
Q3
$5.02M Sell
74,057
-13,208
-15% -$895K 0.01% 886
2016
Q2
$4.84M Buy
87,265
+17,529
+25% +$973K 0.01% 872
2016
Q1
$4.38M Buy
69,736
+15,965
+30% +$1M 0.01% 868
2015
Q4
$5.06M Buy
53,771
+21,003
+64% +$1.98M 0.01% 833
2015
Q3
$2.63M Sell
32,768
-15,115
-32% -$1.21M ﹤0.01% 943
2015
Q2
$5.74M Buy
47,883
+45,965
+2,397% +$5.51M 0.01% 788
2015
Q1
$201K Buy
1,918
+82
+4% +$8.59K ﹤0.01% 1643
2014
Q4
$178K Sell
1,836
-51
-3% -$4.94K ﹤0.01% 1524
2014
Q3
$147K Buy
1,887
+51
+3% +$3.97K ﹤0.01% 1562
2014
Q2
$116K Buy
1,836
+75
+4% +$4.74K ﹤0.01% 1636
2014
Q1
$118K Hold
1,761
﹤0.01% 1658
2013
Q4
$113K Sell
1,761
-69,328
-98% -$4.45M ﹤0.01% 1688
2013
Q3
$4.55M Sell
71,089
-10,100
-12% -$646K 0.01% 790
2013
Q2
$2.52M Buy
+81,189
New +$2.52M 0.01% 882